Clinical Trials for Tessa Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Tessa Therapeutics

Clinical Trials (3)

Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy

PHASE1Active, not recruiting

15 participants

Started: Jul 25, 2022 · Completed: Dec 15, 2037

3 conditions2 sponsors5 locations

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

PHASE1Active, not recruiting

21 participants

Started: Sep 8, 2021 · Completed: Mar 31, 2036

5 conditions1 sponsor4 locations

Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

PHASE2Active, not recruiting

97 participants

Started: Feb 1, 2021 · Completed: Mar 31, 2037

4 conditions1 sponsor5 locations